Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
Philip L. McCarthy(Roswell Park Comprehensive Cancer Center), Charles Linker(University of California, San Francisco), Steven M. Devine(National Marrow Donor Program), Teresa Gentile(State University of New York), Muzaffar H. Qazilbash(The University of Texas MD Anderson Cancer Center), Michele Seiler(University of Chicago), Craig C. Hofmeister(The Ohio State University), Cara A. Rosenbaum(Cornell University), Linda R. Bressler(University of Chicago), John Postiglione, Ravi Vij(Washington University in St. Louis), Edward A. Stadtmauer(University of Pennsylvania), Kouros Owzar(Duke University), Luis Isola(Mount Sinai Medical Center), Parameswaran Hari(Medical College of Wisconsin), Kenneth C. Anderson(Dana-Farber Cancer Institute), Asad Bashey, Natalie S. Callander(University of Wisconsin–Madison), Paul G. Richardson(Harvard University), Koen van Besien(University Hospitals of Cleveland), Susan Barry, Hani Hassoun(Memorial Sloan Kettering Cancer Center), Brian McClune(University of Minnesota Medical Center), Michael E. Kelly(University of Chicago), Sergio Giralt(Memorial Sloan Kettering Cancer Center), Daniel J. Weisdorf(University of Minnesota), Thomas Martin(University of California, San Francisco), Richard T. Maziarz(Oregon Health & Science University), Marcelo C. Pasquini(Cleveland Clinic), Jan S. Moreb(University of Florida), Denise Levitan(Duke University), Mary M. Horowitz(Medical College of Wisconsin), Chen Jiang, Elizabeth Bennett, Thomas C. Shea(University of North Carolina at Chapel Hill), Don A. Gabriel(University of North Carolina at Chapel Hill), Robert Schlossman(University of Leeds), Heather Landau(Memorial Sloan Kettering Cancer Center), David D. Hurd(Duke University), Vera Hárs
Cited by 1,140
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k